Single-dose pharmacokinetics of delavirdine mesylate and didanosine in patients with human immunodeficiency virus infection.

Delavirdine is a nonnucleoside reverse transcriptase inhibitor with in vitro activity against human immunodeficiency virus type 1 (HIV-1) that is currently being evaluated in combination regimens with various nucleoside analogs, including didanosine. Due to the pH-dependent solubility of delavirdine...

Descrizione completa

Dettagli Bibliografici

Pubblicato in:	Antimicrob Agents Chemother
Autori principali:	Morse, G D, Fischl, M A, Shelton, M J, Cox, S R, Driver, M, DeRemer, M, Freimuth, W W
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	American Society for Microbiology (ASM) 1997
Soggetti:	Research Article
Accesso online:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC163679/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/8980774/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.41.1.169
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!